ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. ProtoKinetix shares last traded at $0.01, with a volume of 46,500 shares.
ProtoKinetix Stock Performance
The stock has a 50-day simple moving average of $0.01 and a 200 day simple moving average of $0.01.
ProtoKinetix Company Profile
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.
Further Reading
- Five stocks we like better than ProtoKinetix
- The Role Economic Reports Play in a Successful Investment Strategy
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
- 10 Best Airline Stocks to Buy
- AMD’s AI-Powered Stock Price Rally Just Shifted Gears
- Best Aerospace Stocks Investing
- 5 Hot Small-Cap Insiders Bought at the Peak of Tariff Fears
Receive News & Ratings for ProtoKinetix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProtoKinetix and related companies with MarketBeat.com's FREE daily email newsletter.
